VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Director, R&D Data Science & Digital Health – Neuroscience

Johnson & Johnson Innovative Medicine is a leader in healthcare innovation, dedicated to developing smarter and less invasive treatments. The Director of R&D Data Science & Digital Health – Neuroscience will lead efforts to transform neuroscience clinical trials using AI and digital health technologies, focusing on novel digital endpoints and enhancing patient engagement.

Head of Discovery Multiomics

Director, R&D Data Science & Digital Health, Ophthalmology

Director, R&D Data Science

Associate Director Oncology Data Science, R&D

Director, Data Science Neuroscience, Real World Evidence

Sign up with Google

Sign in with Google